Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Biology Institute

Latest From Molecular Biology Institute

Long-Term Risks of Shutting Down VEGF from Inside the Cell

New research shows that production of VEGF -- a master regulator of blood vessel growth -- from within a cell is an important survival mechanism used by that cell, and that shutting it down could pose long-term risks. The work raises a red flag about long-term use of VEGF-inhibiting small-molecule cancer drugs that travel inside a cell to prevent VEGF expression. It also reinforces the importance of advancing methods for direct delivery of these drugs to tumors.
BioPharmaceutical Regulation
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register